DoD Issues SBIR Grants to Biosearch Technologies


Updated : Wed, October 1, 2014 @ 4:33 PM

Originally published : Thu, Oct 08, 2009 @ 08:13 AM

Biosearch Technologies has been selected for two Small Business Innovative Research (SBIR) grants from the Department of Defense (DoD). Both Phase 1 grants calls for the development of highly sensitive analyte specific reagents (ASRs) for a total of twelve pathogens.  The ASRs are qPCR based, but modified for field deployment.  Both grants include the following target pathogens: Dengue, Rift Valley Fever, Sand Fly Fever, Crimean-Congo Hemorrhagic Fever, Tick-Borne Encephalitis, Chikungunya, causative agents of typhus, spotted fever, anaplasmosis, Ehrlichioses, and Q fever.  If Phase I turns out to be a success, Biosearch expects this project to lead into a multiyear Phase II award.

To read the entire story, read the full press release.

Or, read more about the products and services Biosearch offers for ASR manufacturing.

Leave a comment

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!